![]() |
市场调查报告书
商品编码
1887037
眼科超音波市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察,以及2024年至2032年的预测Ophthalmic Ultrasound Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
由于眼部疾病的增加、技术创新以及先进眼科诊断设备的引入,全球眼科超音波市场持续稳定成长。据报道,该市场规模在2024年达到2.839亿美元,2025年成长至3.037亿美元,到2032年将达4.996亿美元。这意味着2025年至2032年期间的复合年增长率高达7.4%,证实了市场对眼科影像技术的长期持续需求。
眼科超音波设备可帮助眼科医师观察眼内结构,包括视网膜、眼眶、玻璃体和眼前节。这些影像工具在诊断青光眼、糖尿病视网膜病变、玻璃体出血、肿瘤和外伤相关眼部併发症方面发挥着至关重要的作用。远视、白内障和青光眼在全球的发病率不断上升,推动了对精准诊断设备的需求。例如,Crystal Vision Ltd. 估计,到 2025 年底,全球 30.6% 的成年人将患有远视,这凸显了早期检测技术的必要性。
北美将在 2024 年保持领先地位,市占率达 42.40%
北美在 2024 年以 42.40% 的市占率引领全球市场,创造了 1.204 亿美元的收入。该地区的领先地位归功于先进的医疗基础设施、成像工具在临床环境中的广泛应用以及各种眼部患者病率的不断上升。根据美国疾病管制与预防中心 (CDC) 2024 年的数据,美国有 420 万人患有青光眼,其中 150 万人患有影响视力的青光眼。如此高的疾病负担推动了临床对眼科诊断设备的需求。 Micro Medical Devices (MMD)、Keeler 和 Nidek 等公司积极参与医疗展览和会议,也有助于提高人们对眼科疾病的认识,并促进其产品的普及应用。
市场驱动因素:眼科疾病负担日益加重
全球远视、青光眼、老年黄斑部病变 (AMD) 和糖尿病视网膜病变的发生率持续上升,因此迫切需要能够早期检测的眼科超音波系统。根据Crystal Vision Ltd.预测,到2025年底,远视将影响37.2%的美国成年人和23.1%的欧洲成年人。这些疾病的诊断和手术方案製定都需要精准的影像检查,而眼科超音波设备仍是有效疾病管理的关键工具。
市场限制因素:高成本与替代技术的涌现
儘管需求不断增长,但眼科超音波系统的普及受到设备成本高昂的限制,其价格通常在5,500美元到20,000美元之间。这限制了低收入地区和小型医疗机构对这些设备的使用。此外,由于其先进的诊断能力,临床医生越来越倾向于使用其他先进的影像技术(如光学相干断层扫描(OCT)、眼底成像、磁振造影(MRI)等)。新型OCT设备的出现,例如NIDEK公司于2024年6月发布的RS-1青光眼OCT设备,正在加剧传统超音波设备的竞争压力。
机会:医疗基础设施的扩展
全球眼科诊所、眼科医院和专业诊断中心的不断涌现,带来了新的市场机会。例如,雪梨眼科医院的 Gadigal 眼科诊所于 2024 年 10 月开业,提升了澳洲的诊断能力。诸如 LVPEI 于 2025 年 3 月举办的 "青光眼宣传週" 等眼部保健宣传活动,进一步促进了早期筛检,并支撑了对诊断超音波设备的需求。
技术趋势:便携式 3D 超音波设备的兴起
技术创新持续影响眼科超音波市场。可携式手持设备,例如 Quantel Medical 的 Pocket III 角膜厚度计和 Keeler 的配备 A 型扫描探头的 4Sight(于 2024 年 5 月上市),因其便携性、准确性和易用性而日益受到欢迎。同时,3D超音波成像正在成为一种变革性趋势,提高了诊断准确性,并为临床决策提供了更全面的可视化效果。
The global ophthalmic ultrasound market is witnessing steady expansion driven by rising eye-related disorders, technological innovation, and the introduction of advanced ocular diagnostic devices. As reported in 2024, the market size reached USD 283.9 million, with projections indicating growth to USD 303.7 million in 2025, and eventually USD 499.6 million by 2032. This reflects a strong CAGR of 7.4% from 2025 to 2032, signaling sustained long-term demand for ophthalmic imaging technologies.
Ophthalmic ultrasound devices support ophthalmologists in visualizing the internal structures of the eye, including the retina, orbit, vitreous, and anterior segment. These imaging tools play a critical role in diagnosing glaucoma, diabetic retinopathy, vitreous hemorrhage, tumors, and trauma-related ocular complications. Rising global cases of hyperopia, cataracts, and glaucoma are boosting the need for accurate diagnostic instruments. For instance, Crystal Vision Ltd. estimated that 30.6% of adults worldwide will suffer from hyperopia by the end of 2025, emphasizing the need for early detection technologies.
North America Leads with 42.40% Market Share in 2024
North America dominated the global market in 2024 with a 42.40% share, generating USD 120.4 million in revenue. The region's leadership is attributed to advanced healthcare infrastructure, widespread clinical adoption of imaging tools, and increased prevalence of various ocular diseases. According to CDC data from 2024, 4.2 million people in the U.S. were living with glaucoma, including 1.5 million individuals with vision-affecting glaucoma. The high disease burden strengthens demand for ophthalmic diagnostic devices across clinical settings. Active participation of companies such as Micro Medical Devices (MMD), Keeler, and NIDEK at medical expos and conferences also contributes to increased product visibility and adoption.
Market Drivers: Growing Burden of Eye Disorders
Global incidences of hyperopia, glaucoma, AMD, and diabetic retinopathy continue to rise, creating an urgent need for ophthalmic ultrasound systems capable of early detection. Hyperopia alone is projected to impact 37.2% of adults in America and 23.1% in Europe by the end of 2025, according to Crystal Vision Ltd. These conditions require precise imaging for both diagnosis and surgical planning, and ophthalmic ultrasound remains a crucial tool toward effective disease management.
Market Restraints: High Costs and Availability of Alternatives
Despite growing demand, the adoption of ophthalmic ultrasound systems is limited by high device costs, which typically range from USD 5,500 to USD 20,000. This restricts availability in lower-income regions and smaller medical establishments. Moreover, advanced imaging alternatives-such as Optical Coherence Tomography (OCT), fundus imaging, and MRI-are increasingly favored by clinicians for their sophisticated diagnostic capabilities. The launch of new OCT devices, such as NIDEK's RS-1 Glaucoma OCT system in June 2024, adds competitive pressure on traditional ultrasound methods.
Opportunities: Healthcare Infrastructure Expansion
Increasing establishment of ophthalmic clinics, eye hospitals, and specialized diagnostic centers worldwide provides new market opportunities. For example, the Gadigal Eye Clinic at Sydney Eye Hospital, launched in October 2024, expanded diagnostic capacity in Australia. Eye-care awareness programs, such as Glaucoma Awareness Week by LVPEI in March 2025, further encourage early screening and bolster demand for diagnostic ultrasound devices.
Technology Trends: Portable & 3D Ultrasound Devices Gain Traction
Technological advancements continue to shape the ophthalmic ultrasound market. Portable and handheld devices-such as Quantel Medical's Pocket III pachymeter launched in May 2024 and Keeler's 4Sight with A-Scan probe-are gaining popularity due to their mobility, accuracy, and ease of use. Meanwhile, 3D ultrasound imaging is emerging as a transformative trend, enhancing diagnostic precision and offering more comprehensive visualization for clinical decision-making.
Competitive Landscape
Major companies in the market include Keeler, HAI Laboratories, Micro Medical Devices (MMD), Lumibird Medical, NIDEK CO., LTD., Sonomed Escalon, and DGH Technology. Expansion strategies and manufacturing upgrades are key competitive factors. A notable development occurred in February 2025, when Keeler opened a new state-of-the-art manufacturing facility in Shanghai, strengthening localized production and supporting rising demand in China.
Segmentation By Product
By Device Type
By Imaging Type
By End-user
By Region